BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
Holding BVAXF?
Track your performance easily

BioVaxys Technology (BVAXF) Financial Statements

29 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently ―. The company's EPS TTM is $-0.025; its P/E ratio is -1.70; BioVaxys Technology is scheduled to report earnings on September 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 24Jan 24Oct 23Jul 23Apr 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -542.39KC$ 518.05KC$ -3.67MC$ -1.58MC$ -1.49M
EBITDAC$ -542.39KC$ 518.05KC$ -3.67MC$ -1.58MC$ -1.49M
Net Income Common StockholdersC$ -542.39KC$ 518.05KC$ -3.67MC$ -1.58MC$ -1.49M
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 159.74KC$ 965.13KC$ 977.00C$ 423.00C$ 28.48K
Total AssetsC$ 1.77MC$ 1.48MC$ 113.48KC$ 1.41MC$ 2.65M
Total DebtC$ 64.96KC$ 98.13KC$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -94.78KC$ -867.01KC$ -977.00C$ -423.00C$ -28.48K
Total LiabilitiesC$ 2.79MC$ 2.87MC$ 3.49MC$ 2.04MC$ 1.76M
Stockholders EquityC$ -1.03MC$ -1.40MC$ -3.37MC$ -624.21KC$ 897.57K
Cash Flow-
Free Cash FlowC$ -1.49MC$ 2.38KC$ -2.02KC$ -23.74KC$ -711.83K
Operating Cash FlowC$ -436.93KC$ 2.38KC$ -2.02KC$ -23.74KC$ -711.83K
Investing Cash FlowC$ -1.06M----
Financing Cash FlowC$ 687.94KC$ 962.67K--C$ 670.00K
Currency in CAD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis